Annotation Detail

Information
Associated Genes
ABL1
Associated Variants
ABL1 p.Glu274Lys (p.E274K) ABL1 p.Glu274Lys (p.E274K)
Associated Disease
chronic myeloid leukemia
Source Database
CIViC Evidence
Description
In a phase II study of 60 imatinib-resistant patients with BCR-ABL mutations, 6 had E255K mutations
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/7039
Gene URL
https://civic.genome.wustl.edu/links/genes/4
Variant URL
https://civic.genome.wustl.edu/links/variants/3
Rating
1
Evidence Type
Predictive
Disease
Chronic Myeloid Leukemia
Evidence Direction
Supports
Drug
Imatinib Mesylate
Evidence Level
C
Clinical Significance
Resistance
Pubmed
17264298
Drugs
Drug NameSensitivitySupported
Imatinib MesylateResitance or Non-Reponsetrue